Lots of New German Medications in 2020

Lots of Lots of New New German German

Medications Medications

Coronavirus may have dominated the headlines last year, but Germany’s pharmaceutical companies were busy fighting disease on a number of fronts.

The German Association of Research-Based Pharmaceutical Companies (vfa) says that its members brought 32 medications with new active ingredients on the market in 2020. They include not only the Covid-19 vaccine developed by BioNTech and US partner Pfizer but also ten medications to combat cancer.

“With the first Covid-19 vaccine, companies and regulatory authorities have started to the turn the tide of the pandemic,” said vfa President Han Steutel in a statement. “At the same time, companies continued to bring out new medications for patients with other diseases in 2020.”

The vfa added that its members invest more than EUR 7 billion a year in medication research.

in 2020 in 2020

Source : https://www.marketsgermany.com/lots-of-newgerman-medications-in-2020/